Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Precision Biosciences Inc (DTIL)

Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Precision Biosciences Inc 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 USA

www.precisionbiosciences.com P: 919-314-5512 F: 480-393-5553

Description:

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 80,366
Enterprise Value, $K -36,314
Shares Outstanding, K 6,916
Annual Sales, $ 48,730 K
Annual Net Income, $ -61,320 K
Last Quarter Sales, $ 7,040 K
Last Quarter Net Income, $ -16,290 K
EBIT, $ -43,730 K
EBITDA, $ -35,990 K
60-Month Beta 1.62
% of Insider Shareholders 5.10%
% of Institutional Shareholders 37.99%
Float, K 6,563
% Float 94.90%
Short Volume Ratio 0.62

Growth:

1-Year Return -46.42%
3-Year Return -96.25%
5-Year Return -97.18%
5-Year Revenue Growth 347.89%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.35 on 03/27/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -16.26
EPS Growth vs. Prev Qtr -11.56%
EPS Growth vs. Prev Year 57.09%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/14/24

DTIL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -143.60%
Return-on-Assets % -23.27%
Profit Margin % -125.84%
Debt/Equity 0.00
Price/Sales 1.63
Price/Cash Flow N/A
Price/Book 2.35
Book Value/Share 4.53
Interest Coverage -18.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar